PUBLISHER: 360iResearch | PRODUCT CODE: 1465109
PUBLISHER: 360iResearch | PRODUCT CODE: 1465109
[197 Pages Report] The Minimally Invasive Surgery Market size was estimated at USD 71.96 billion in 2023 and expected to reach USD 81.21 billion in 2024, at a CAGR 13.28% to reach USD 172.37 billion by 2030.
Minimally invasive surgery is a surgical intervention that is performed through tiny incisions instead of large openings. This approach utilizes specialized instruments and a camera to guide the surgery, making it possible for patients to experience less pain, reduced scarring, and a quicker patient recovery time compared to traditional open surgery. There is a growing preference among patients for surgeries that cause minimal disruption to their bodies and lives, driving the adoption of minimally invasive techniques. Minimally invasive surgeries often result in shorter hospital stays and quicker recoveries, which can significantly reduce healthcare costs for patients and insurance providers. Government initiatives to improve the accessibility of patients for surgical interventions and lower the cost of medical services have led to the growing adoption of minimally invasive surgeries. However, the intricate design and operation of minimally invasive surgical tools require significant training and skill, which can pose a challenge in their widespread adoption. The risk of infection, health risks, and complexities associated with insurance coverage can hamper the adoption of minimally invasive surgeries and instruments. Continued advancements in robotic surgery are expected to enhance precision and flexibility during operations, making minimally invasive procedures accessible for a wider range of conditions and also improving the safety and efficiency of surgical interventions. Increased focus on training healthcare professionals in minimally invasive techniques can reduce the skill gap, improving surgical outcomes. The integration of surgical data with digital health records could greatly improve post-surgery monitoring and personalized patient care, maximizing the benefits of minimally invasive procedures.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 71.96 billion |
Estimated Year [2024] | USD 81.21 billion |
Forecast Year [2030] | USD 172.37 billion |
CAGR (%) | 13.28% |
Type: Adoption of minimally invasive surgeries for orthopedic procedures to ensure less pain, quicker recovery, and minimal scarring
In cardiovascular care, minimally invasive surgery is used to address heart and blood vessel issues with smaller incisions. Procedures can include heart valve repairs, coronary artery bypass, and heart defect repairs. The aim is to reduce recovery time and complications, making heart surgery less daunting for patients. Cosmetic minimally invasive surgeries focus on enhancing appearance with the least possible disruption to the body. These can range from botox injections to liposuction and facelifts performed with tiny incisions and instruments. This approach reduces scarring and recovery periods, making cosmetic improvements more accessible and less risky. Gastrointestinal surgery involves surgeries of the digestive tract, including the esophagus, stomach, small intestine, large intestine, and rectum, utilizing minimally invasive techniques. Conditions such as hernias, gallbladder stones, and gastrointestinal cancers can be treated. The approach seeks to minimize post-operative discomfort and facilitate a quicker return to normal activities. Minimally invasive techniques in gynecological surgery address disorders of the female reproductive system. Common procedures include treatments for uterine fibroids, ovarian cysts, endometriosis, and hysterectomies (removal of the uterus). These methods help in reducing the healing time and improving the overall surgical experience for women. Orthopedic surgery focuses on conditions involving the musculoskeletal system. Minimally invasive techniques can be applied in joint replacements, repairing soft tissue injuries, and correcting bone deformities. Smaller incisions result in lesser tissue damage, leading to quicker recovery times and diminished pain post-operation. Urological minimally invasive surgeries treat conditions affecting the urinary tract and male reproductive organs, including procedures and surgical interventions such as kidney stone removal, prostate surgery, and cancer treatments. Techniques such as laparoscopy and robotic-assisted surgery have improved urology care by making surgeries less invasive.
End Users: Expansion of hospitals across the world owing to their capacity to provide immediate, comprehensive post-operative care
Ambulatory surgical centers(ASC) refer to facilities where surgeries that do not need long hospital admission are performed. These centers specialize in providing surgical services, including minimally invasive surgery, to patients who can go home on the same day of their procedure. Given their focus on efficiency and cost-effectiveness, ASCs have increasingly adopted minimally invasive surgery techniques for a variety of procedures, particularly those deemed low to moderate in complexity. Their usage of minimally invasive surgery is significant due to the nature of ASC favoring surgeries with quicker recovery times. Hospitals encompass the broadest range of surgeries, including both minimally invasive and traditional open surgeries. They are equipped with advanced medical facilities and staffed by a diverse team of specialists, allowing them to perform a wide array of minimally invasive surgery procedures, from basic to highly complex. Hospitals are arguably the most versatile settings for minimally invasive surgery due to their extensive resources, including specialized surgery rooms and recovery units. They cater to a wide patient demographic, handling emergency surgeries, complicated procedures, and surgeries requiring extensive post-operative care. Given their comprehensive capabilities, hospitals are likely the primary setting for MIS, particularly for procedures that demand significant post-surgery monitoring or entail high complexity. Specialty clinics are healthcare facilities focusing on a specific field of medicine, providing targeted care, including diagnostic services, treatment, and surgeries related to their area of specialization. For minimally invasive surgery, specialty clinics often concentrate on specific types of minimally invasive procedures that fall within their expertise, such as orthopedics, gynecology, or gastroenterology. While specialty clinics extensively use minimally invasive surgery techniques within their focus areas, their overall use of minimally invasive surgery across the full spectrum of potential procedures is naturally more limited compared to hospitals due to their specialized nature.
Regional Insights
The Americas region, particularly the United States and Canada, is at the forefront in adopting the latest minimally invasive surgical technologies due to their well-established healthcare infrastructure, high patient awareness, and significant healthcare spending. The consumer need is largely driven by the desire for quicker recovery times and less invasive treatment options. The region experiences continuous investment in research, leading to a robust pipeline of innovations and patents designed to make surgeries more precise and less traumatic. Recent initiatives include the integration of robotics and artificial intelligence (AI) to further refine surgical outcomes. Europe represents a mature landscape for minimally invasive surgery, prompted by both the growing aging population and the region's commitment to high-quality healthcare standards. Government and private funding in healthcare research are substantial, focusing on enhancing surgical tools and methodologies. Moreover, the presence of stringent regulations pertaining to the development, efficiency, safety, and reliability of medical equipment and devices has created a standardized framework for minimally invasive surgical equipment and solutions, creating a ripe landscape for the development of safe medical products. The APAC region is witnessing a significant surge in the need for minimally invasive surgery solutions, attributed to rising healthcare expenditures, growing middle-class populations, and an increasing number of hospitals. In China and India, government initiatives aimed at enhancing healthcare services and increasing foreign investments in the medical sector provide a considerable push. Japan, known for its technological advancements, is a key innovator in developing surgical robotics. Patient preference for cost-effective and affordable surgical interventions and government support for improving public health has created a conducive landscape for the adoption of minimally invasive surgery solutions.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Minimally Invasive Surgery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Minimally Invasive Surgery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Minimally Invasive Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arthrex, Inc., B. Braun SE, Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated by The Cooper Companies, Inc., Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Getinge AB, Hoya Corporation, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Koninklijke Philips N.V., Livanova PLC, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers, Smith & Nephew plc, Stryker Corporation, Synaptive Medical Inc., Teleflex Incorporated, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Minimally Invasive Surgery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Minimally Invasive Surgery Market?
3. What are the technology trends and regulatory frameworks in the Minimally Invasive Surgery Market?
4. What is the market share of the leading vendors in the Minimally Invasive Surgery Market?
5. Which modes and strategic moves are suitable for entering the Minimally Invasive Surgery Market?